Biologics Development & Manufacturing

Eurofins CDMO Alphora is a Canadian contract development and manufacturing organization (CDMO) with FDA- and Health Canada-inspected facilities, providing end-to-end development and manufacturing solutions for mammalian cell culture-based biologics. Our integrated capabilities encompass cell line development, process development and optimization, analytical development, GMP manufacturing, and aseptic fill-finish services to support biologic programs from early development through commercial supply.

We specialize in the development and manufacture of complex biologic modalities, including monoclonal antibodies (mAbs), biosimilars, virus-like particles (VLPs), multispecific antibodies, and antibody-drug conjugates (ADCs). Leveraging deep scientific expertise and flexible manufacturing capabilities, we help sponsors accelerate development timelines, mitigate technical and regulatory risks, and efficiently advance products through clinical development and commercialization.

By combining robust development expertise with scalable GMP manufacturing and comprehensive analytical support, we provide a seamless pathway from process characterization and clinical supply production to long-term commercial success.